Induction of Leukemia-specific CD8+ Cytotoxic T Cells with Autologous Myeloid Leukemic Cells Maturated with a Fiber-modified Adenovirus Encoding TNF-alpha
Overview
Pharmacology
Affiliations
Acute myeloid leukemia (AML) cells can be differentiated into dendritic cells (DCs) using appropriate combinations of cytokines but generation of autologous antileukemic cytotoxic T cells using leukemic DCs remains difficult. Transduction by adenoviral vectors has been reported to induce efficient maturation of monocyte-derived DCs but AML cells are generally resistant to adenoviral gene transfer. In this study we tested the effects of adenoviral TNF-alpha gene transfer on maturation of AML cells using the fiber-modified AdTNF.F(pK7) adenovirus. All samples expressed high and sustained levels of TNF-alpha following transduction. AdTNF.F(pK7) induced significantly greater maturation of AML cells into antigen-presenting cells (APC) than did recombinant TNF-alpha or control adenoviral vector. Maturation of leukemic cells into APCs was mediated at least partially via a PI3K/mTOR pathway, as the inhibitors LY294002, wortmannin, and rapamycin inhibited the maturation effect induced by the AdTNF.F(pK7) adenovirus. In addition, CD8+ T cells expanded with AdTNF.F(pK7)-transduced AML cells showed greater expansion and specific CD8+ CTL activity against autologous AML cells than T cells expanded by other means. Thus, fiber-modified adenoviral vectors encoding TNF-alpha are able to maturate AML cells into APCs with high efficacy and reproducibility, providing a useful tool to generate efficiently specific CD8+ CTLs against leukemic disease.
Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy.
Mercogliano M, Bruni S, Mauro F, Elizalde P, Schillaci R Cancers (Basel). 2021; 13(3).
PMID: 33540543 PMC: 7985780. DOI: 10.3390/cancers13030564.
Li G, Wu H, Cui L, Gao Y, Chen L, Li X Oncotarget. 2015; 6(41):43496-507.
PMID: 26554307 PMC: 4791246. DOI: 10.18632/oncotarget.6292.
Clinical evaluation of cellular immunotherapy in acute myeloid leukaemia.
Smits E, Lee C, Hardwick N, Brooks S, Van Tendeloo V, Orchard K Cancer Immunol Immunother. 2011; 60(6):757-69.
PMID: 21519825 PMC: 11029703. DOI: 10.1007/s00262-011-1022-6.
Berthon C, Driss V, Liu J, Kuranda K, Leleu X, Jouy N Cancer Immunol Immunother. 2010; 59(12):1839-49.
PMID: 20814675 PMC: 2945474. DOI: 10.1007/s00262-010-0909-y.